A Study of TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC)
Clinical trial NCT04325763 · UNKNOWN
Trial details
- NCT number
- NCT04325763
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-27
- Primary completion
- 2022-12-01
- Enrollment
- 315
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.